(Q40196769)

18 September 2017

The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

18 September 2017

1 reference

1 reference

6

Boguslawa Baranowska

1 reference

18 September 2017

Agnieszka Baranowska-Bik

series ordinal

2

object named as

Agnieszka Baranowska-Bik

1 reference

18 September 2017

1

Wojciech Bik

1 reference

18 September 2017

Ewa Wolinska-Witort

3

1 reference

18 September 2017

Magdalena Chmielowska

series ordinal

4

1 reference

18 September 2017

Lidia Martynska

series ordinal

5

1 reference

18 September 2017

1 June 2007

1 reference

Gynecological Endocrinology

18 September 2017

1 reference

18 September 2017

23

1 reference

18 September 2017

6

1 reference

18 September 2017

325-331

1 reference

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

18 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

A role for ghrelin in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Biological, physiological, and pharmacological aspects of ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Serum adiponectin concentration and cardiovascular risk factors in climacteric women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Visceral obesity and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Serum adiponectin levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

The relationship between active ghrelin levels and human obesity involves alterations in resting energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701260169

10.1080/09513590701260169

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference